0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Continued Dependence on Nicotine Replacement Therapy Should Be Reported and Discussed in Smoking Cessation Trials

Julius Gylys, PhD
Arch Intern Med. 2000;160(13):2061-2067. doi:.
Text Size: A A A
Published online

Extract

In their trial of 4 nicotine replacement therapy (NRT) products, Hajek and colleagues1 concluded that there were no notable differences in general efficacy among the tested nicotine patch, gum, nasal spray, and inhaler. Indeed, the withdrawal scores, urges to smoke indices, and abstinence rates for patients randomized to each of the 4 groups were not statistically different from one another at the 12-week follow-up. What is notable, however, is that among the participants who were not smoking at 12 weeks, a majority continued to use NRT products. Specifically, 53.8% (14/68), 74.2% (23/54), 76.0% (19/64), and 90.0% (27/68) of patch, inhaler, gum, and nasal spray users, respectively, continued to use their prescribed NRT products. Furthermore, post hoc comparisons indicated that the patch group showed significantly less continued NRT use than those participants using the other 3 NRT products.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
brightcove.createExperiences();